Atlas Trials

Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B

Clinical trial NCT01369199 · TERMINATED

Trial details

NCT number
NCT01369199
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2012-05-01
Primary completion
2017-02-14
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.